Dr. Given is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
225 Clearfield Ave
Virginia Beach, VA 23462Phone+1 757-457-5177Fax+1 757-962-8020
Education & Training
University of FloridaResidency, Urology, 1993 - 1994
Virginia Commonwealth University Health SystemResidency, Urology, 1990 - 1993- Virginia Commonwealth University Health SystemResidency, Surgery, 1988 - 1990
Virginia Commonwealth University School of MedicineClass of 1988
Certifications & Licensure
VA State Medical License 1990 - 2026
NC State Medical License 1995 - 2025- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Start of enrollment: 2004 Jan 01
- Salvage Cryotherapy in Recurrent Prostate Cancer Start of enrollment: 2007 Jan 01
- Initiation of Androgen Deprivation Therapy for Prostate Cancer Using Degarelix Followed by Leuprolide Start of enrollment: 2011 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 761 citationsApalutamide for Metastatic, Castration-Sensitive Prostate Cancer.Kim N. Chi, Neeraj Agarwal, Anders Bjartell, Byung Ha Chung, Andrea J. Pereira de Santana Gomes
The New England Journal of Medicine. 2019-05-31 - 14 citationsSelective estrogen receptor alpha agonist GTx-758 decreases testosterone with reduced side effects of androgen deprivation therapy in men with advanced prostate cancerEvan Y. Yu, Robert H. Getzenberg, Christopher C. Coss, Marc M. Gittelman, Thomas E. Keane
European Urology. 2015-02-01 - 61 citationsHealth-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, ...Neeraj Agarwal, Kelly McQuarrie, Anders Bjartell, Simon Chowdhury, Andrea J. Pereira de Santana Gomes
The Lancet. Oncology. 2019-11-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
